At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA
In Brief
A clinical study evaluating Experimental: Interventional Cohort: TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System, Standard of Care Surgery, and 2 other interventions for Chronic Subdural Hematoma. Completed, enrolled 376 participants across 33 sites in 2 countries.
Signals
Detailed Summary
This is a prospective, multi-center, open-label, randomized controlled study in which subjects can receive standard of care (SOC) alone or SOC and TRUFILL n-BCA MMA embolization for the treatment of chronic subdural hematomas (cSDH).
Study Details
Timeline
Arms & Interventions
Standard of Care Surgery + Embolization
Standard of Care Surgery Only
Standard of Care Medical Management + Embolization
Standard of Care medical management only.
Interventions
Standard of Care Surgery + Embolization
Standard of Care Surgery Only
Standard of Care Medical Management + Embolization
Standard of Care Medical Management Only